Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MyKidz Iron
- Development stage
- Unknown
- Lead developer
- Tris Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MyKidz Iron is a pediatric nutritional supplement developed by Tris Pharma, Inc., specifically designed for the prevention and treatment of iron deficiency and iron deficiency anemia in infants and children. The product is delivered as a liquid oral suspension and features a patent-pending polymeric matrix technology that complexes elemental iron to mask its metallic taste and prevent the common side effect of tooth staining. Each 2 mL dose provides 10 mg of elemental iron along with essential vitamins, including Vitamin A (1500 IU), Vitamin C (35 mg), and Vitamin D (400 IU), which support overall growth and can aid in the absorption and utilization of iron.
- Brand names
- MyKidz Iron
Beyond the preview
Go deeper on MyKidz Iron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MyKidz Iron.